In another study, researchers constructed a miRNA-mRNA regulatory network containing miR-106b-5p to identify genes such as TMEM100, FRMD6, NBL1, and STARD4 for the diagnosis and prognosis of prostate cancer patients. This evidence concerns the gene TMEM100 and prostate carcinoma.